Theratechnologies Announces Publication in Frontiers in Immunology that Deepens Understanding of Sudocetaxel Zendusortide (TH1902) Molecular Mechanism of Action

Stock Information for Theratechnologies Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Theratechnologies Inc.

Target Hospitality Announces Partnership with Chard Métis Dene Group
Target Hospitality Receives Buyout Offer from TDR Capital
Target Hospitality Reports Impressive 2023 Results Further Strengthening Financial Position Focused on Value Enhancing Capital Allocation Opportunities
Target Hospitality Announces Fourth Quarter and Full Year 2023 Earnings Release and Conference Call Schedule
Theratechnologies Announces the Resignation of One of Its Directors, Mr. Alain Trudeau
Theratechnologies Receives Refusal to File Letter for Trogarzo® Intramuscular Method of Administration sBLA from FDA
Theratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2023 and Provides 2024 Guidance
Target Hospitality Announces Appointment of John C. Dorman to Board of Directors

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.